SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-192011
Filing Date
2022-07-12
Accepted
2022-07-12 16:17:03
Documents
16
Period of Report
2022-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d700827d8k.htm   iXBRL 8-K 38886
2 EX-3.1 d700827dex31.htm EX-3.1 10086
3 EX-3.2 d700827dex32.htm EX-3.2 16625
4 EX-10.1 d700827dex101.htm EX-10.1 26693
5 EX-99.1 d700827dex991.htm EX-99.1 8317
  Complete submission text file 0001193125-22-192011.txt   257357

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA alna-20220712.xsd EX-101.SCH 2873
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE alna-20220712_lab.xml EX-101.LAB 20247
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alna-20220712_pre.xml EX-101.PRE 12614
10 EXTRACTED XBRL INSTANCE DOCUMENT d700827d8k_htm.xml XML 3862
Mailing Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462
Business Address ONE NEWTON EXECUTIVE PARK SUITE 202 NEWTON MA 02462 617-467-4577
Allena Pharmaceuticals, Inc. (Filer) CIK: 0001624658 (see all company filings)

IRS No.: 452729920 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38268 | Film No.: 221079332
SIC: 2836 Biological Products, (No Diagnostic Substances)